A.I.

bg
AWS and Bluesight build AI for hospital 340B compliance

AWS and Bluesight build AI for hospital 340B compliance

AWS (Amazon Web Services) has explained how Bluesight developed Prism, an AI lay...

bg
Nokia’s AI-RAN platform: a radio comeback that runs on NVIDIA

Nokia’s AI-RAN platform: a radio comeback that runs on ...

Nokia’s AI-RAN platform arrived on July 15 with a claim worth examining: that it...

bg
Neko Health raises $700 million to expand AI body scans in the US

Neko Health raises $700 million to expand AI body scans...

Neko Health has raised $700 million to expand its AI body scans in the United St...

bg
Examining Google DeepMind’s AI bioresilience push

Examining Google DeepMind’s AI bioresilience push

Google DeepMind and Isomorphic Labs outlined a bioresilience program to curb AI ...

bg
AWS GraphRAG deployment cuts drug research cycles by 87%

AWS GraphRAG deployment cuts drug research cycles by 87%

A recent AWS GraphRAG deployment reduced drug research and development cycles in...

bg
How to shrink the token budget without shrinking the team

How to shrink the token budget without shrinking the team

Jensen Huang has a test for whether an engineer is worth keeping, and it comes w...

bg
AI agent crawlers now need permission. Here’s how to get it

AI agent crawlers now need permission. Here’s how to ge...

AI agent crawlers, the bots that fetch pages in real time on behalf of a person ...

bg
Takeda signs $600M AI drug discovery deal with Insilico

Takeda signs $600M AI drug discovery deal with Insilico

Takeda has entered a strategic collaboration with Hong Kong-based Insilico Medic...

bg
China’s AI companion rules: what Beijing is really going after

China’s AI companion rules: what Beijing is really goin...

An AI companion sounds dystopian, but it has become a common thread in the wider...

bg
L’Oreal, Mondelez, and Nestle use AI to speed product development

L’Oreal, Mondelez, and Nestle use AI to speed product d...

L’Oreal is using AI to shorten product development timelines and identify new us...

bg
Insilico Medicine advances AI drug for IPF to Phase III trials

Insilico Medicine advances AI drug for IPF to Phase III...

Insilico Medicine is advancing to Phase III human trials for testing a drug iden...

bg
NHS AI blood test could reduce invasive womb cancer checks

NHS AI blood test could reduce invasive womb cancer checks

Several NHS hospitals are preparing to use an AI-powered blood test to help asse...

bg
Deploying retail AI to scale personalisation and customer insight

Deploying retail AI to scale personalisation and custom...

Optimising retail AI infrastructure drives the successful deployment of personal...

bg
NVIDIA BioNeMo accelerates Anthropic Claude Science

NVIDIA BioNeMo accelerates Anthropic Claude Science

Anthropic Claude Science now integrates the NVIDIA BioNeMo Agent Toolkit to acce...

bg
Takeda signs US$600M AI drug discovery deal with Insilico

Takeda signs US$600M AI drug discovery deal with Insilico

Takeda has entered a strategic collaboration with Hong Kong-based Insilico Medic...

bg
Wimbledon adds IBM AI tools for live match coverage

Wimbledon adds IBM AI tools for live match coverage

The All England Lawn Tennis Club is adding new AI-powered features to Wimbledon’...